Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
23-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #35624
advertisement
Zhang Y
106
Showing records 1 to 25 |
Display all abstracts from
Zhang Y
105142
Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Yang Y
Frontiers in cell and developmental biology
2022; 10: 925835
104977
A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Zhang Y
Eye Contact Lens
2022; 48: 439-444
104700
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Secondary Glaucoma in Patients With Cytomegalovirus-Induced Corneal Endotheliitis
Wu W
Frontiers in microbiology
2022; 13: 940818
104517
Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)
Gao X
BMJ open
2022; 12: e062441
105031
Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Yang Z
Journal of Medicinal Chemistry
2022; 65: 11745-11758
104792
Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology
Mu L
Evidence-based Complementary and Alternative Medicine
2022; 2022: 8336131
105080
Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration
Zhang Y
Frontiers in cellular and infection microbiology
2022; 12: 968992
104762
Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
Zhang Y
Pharmaceutics
2022; 14:
104477
Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Tian F
Neuron
2022; 110: 2607-2624.e8
104628
Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Zhang Y
Acta Ophthalmologica
2023; 101: e50-e60
105019
Non-invasive intracranial pressure estimation using ultrasonographic measurement of area of optic nerve subarachnoid space
Zhang Y
British Journal of Ophthalmology
2023; 107: 1716-1721
104628
Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Hao J
Acta Ophthalmologica
2023; 101: e50-e60
104700
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Secondary Glaucoma in Patients With Cytomegalovirus-Induced Corneal Endotheliitis
Jiang H
Frontiers in microbiology
2022; 13: 940818
105080
Gut microbiota and derived metabolomic profiling in glaucoma with progressive neurodegeneration
Zhou X
Frontiers in cellular and infection microbiology
2022; 12: 968992
104517
Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)
Lv A
BMJ open
2022; 12: e062441
104977
A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Wei Y
Eye Contact Lens
2022; 48: 439-444
104762
Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
Zhang C
Pharmaceutics
2022; 14:
104477
Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Cheng Y
Neuron
2022; 110: 2607-2624.e8
105142
Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Wu J
Frontiers in cell and developmental biology
2022; 10: 925835
105031
Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
Wu J
Journal of Medicinal Chemistry
2022; 65: 11745-11758
104792
Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology
Dong Z
Evidence-based Complementary and Alternative Medicine
2022; 2022: 8336131
105019
Non-invasive intracranial pressure estimation using ultrasonographic measurement of area of optic nerve subarachnoid space
Cao K
British Journal of Ophthalmology
2023; 107: 1716-1721
104762
Research Progress Concerning a Novel Intraocular Lens for the Prevention of Posterior Capsular Opacification
Chen S
Pharmaceutics
2022; 14:
104792
Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology
Zhang Y
Evidence-based Complementary and Alternative Medicine
2022; 2022: 8336131
104477
Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Zhou S
Neuron
2022; 110: 2607-2624.e8
«
1
2
3
4
5
»
Issue
23-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept